Drugs Archives - Page 18 of 65 - ��ýҕ�l Health News

KHN’s ‘What the Health?’: On Government Spending, Congress Decides Not to Decide

Congress has once again decided not to decide how to fund the federal government in time for the start of the fiscal year, racing toward a midnight Sept. 30 deadline to pass a stopgap bill that would keep the lights on for two more months. However, it does appear the FDA’s program that gets drugmakers to help fund some of the agency’s review staff will be renewed in time to stop pink slips from being sent. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Victoria Knight of Axios join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews filmmaker Cynthia Lowen, whose new documentary, “Battleground,” explores how anti-abortion forces played the long game to overturn Roe v. Wade.

Sept. 29, 2022

Centene Agrees to Pay Massachusetts $14 Million Over Medicaid Prescription Claims

Massachusetts is the latest state to settle with St. Louis-based Centene Corp. over allegations that it overcharged Medicaid prescription drug programs.

By Andy Miller and Samantha Young

Sept. 29, 2022

Letters to the Editor

Readers and Tweeters Take a Close Look at Eye Care and White Mulberry Leaf

KHN gives readers a chance to comment on a recent batch of stories.

Sept. 29, 2022

A traditional courtroom illustration, in watercolor and pencil, depicting attorney Lawrence Robbins arguing before the Supreme Court. He wears a black suit, glasses, and is bald.

Doctors Rush to Use Supreme Court Ruling to Escape Opioid Charges

After a unanimous ruling from the high court, doctors who are accused of writing irresponsible prescriptions can go to trial with a new defense: It wasn’t on purpose.

By Brett Kelman

Sept. 19, 2022

A photo shows a medical professional giving a woman a mammogram screening.

Court Ruling May Spur Competitive Health Plans to Bring Back Copays for Preventive Services

The Affordable Care Act required that health insurers provide many medical screenings and prevention services at no out-of-pocket cost to health plan members. But insurers and employers may consider adding cost sharing for preventive services now that a federal court ruled the ACA’s mandate is unconstitutional.

By Harris Meyer

Sept. 15, 2022

A photo shows pills on a bathroom scale surrounded by a human-shaped cookie cutter, suggesting weight loss.

California and New York Aim to Curb Diet Pill Sales to Minors

California and New York would be the first states to require anyone under 18 to obtain prescriptions to purchase over-the-counter weight loss products, which some research has linked to eating disorders.

By Laurie Udesky

Sept. 14, 2022

A macro photo of covid-19 vaccine bottles. The bottles take up the entire image.

PERSPECTIVE

Did the US Jump the Gun With the New Omicron-Targeted Vaccines?

With fears of a winter surge looming, government agencies have authorized and encouraged vaccination with a newly formulated booster. But the science to support that decision remains inconclusive.

By Céline Gounder and Elisabeth Rosenthal

Sept. 12, 2022

��ýҕ�l

‘An Arm and a Leg’: The New Cap on Medicare Drug Costs

In this episode, Julie Rovner, chief Washington correspondent for KHN, guides listeners through decades of dealings between Congress and Big Pharma.

By Dan Weissmann

Sept. 12, 2022

Letters to the Editor

Readers and Tweeters Place Value on Community Services and Life-Sustaining Care

KHN gives readers a chance to comment on a recent batch of stories.

Aug. 19, 2022

Podcast

KHN’s ‘What the Health?’: Wrapping Up Summer’s Health News

President Joe Biden has signed the Inflation Reduction Act and Congress is gone until after Labor Day. But the administration and lawmakers left lots of health policy achievements behind, including new rules to facilitate the sale of over-the-counter hearing aids and a potential reorganization of the Centers for Disease Control and Prevention. Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.

Aug. 18, 2022

A woman with wearing a black T-shirt and orange skirt is filling her car up with gas at the station. The car, to the right of the image, is black and glossy. She faces the gas pump and recoils at the price.

For Medically Vulnerable Families, Inflation’s Squeeze Is Inescapable

Inflation hasn’t hit Americans like this in decades. And families living with chronic diseases have little choice but to pay more for the medicine, supplies, and food they need to stay healthy.

By Heidi de Marco

Aug. 15, 2022

A photo shows the exterior of the U.S. Capitol building.

Big Pharma Went All In to Kill Drug Pricing Negotiations

For more than a century, the drug industry has issued dire warnings of plunging innovation whenever regulation reared its head. In general, the threat hasn’t materialized.

By Arthur Allen

Aug. 12, 2022

KHN & PolitiFact HealthCheck

No, the Senate-Passed Reconciliation Bill Won’t Strip $300 Billion From Medicare

Under the Medicare drug negotiations provisions in the reconciliation bill, the federal government would see its outlays reduced by about $300 billion. That reduction wouldn’t result from cuts in benefits. Instead, Medicare would be empowered to leverage its market power to pay lower prices for certain drugs.

By Louis Jacobson, PolitiFact

Aug. 11, 2022

KHN & PolitiFact HealthCheck

A GOP Talking Point Suggests Birth Control Is Not at Risk. Evidence Suggests Otherwise.

Republicans say Democrats are wrong to claim that birth control could be the Supreme Court’s next target. But Democrats have plenty of evidence that it might be.

By Julie Rovner

Aug. 5, 2022

A screenshot shows Julie Rovner sitting in the PBS Newshour studio.

KHN On Air

Watch: Explaining the Nitty-Gritty of Medicare Drug Price Negotiations — And Patients’ Potential Savings

KHN chief Washington correspondent Julie Rovner discusses the Senate Democrats’ plans to let Medicare negotiate some drug prices, cap out-of-pocket drug costs for seniors, and fund enhanced subsides for ACA marketplace health plans.

Aug. 1, 2022

A photo shows a gloved hand holding a box of paxlovid. A blister pack of tablets is seen on the table.

COVID-19

Everything You Need to Know About Paxlovid — Especially, Should You Take It?

Paxlovid has eclipsed other available therapies for preventing life-threatening covid symptoms in high-risk patients. But even as doctors praise its effectiveness, many say they have unanswered questions about prescribing the drug and want more and better data about it.

By Michelle Andrews

July 28, 2022

KHN On Air

Listen: Can California Lower the Price of Insulin?

California Healthline senior correspondent Angela Hart describes California’s ambitious plan to manufacture generic insulin under the state’s new “CalRx” drug label.

July 27, 2022

KHN & PolitiFact HealthCheck

Ad Targeting Manchin and AARP Mischaracterizes Medicare Drug-Price Negotiations

The advocacy group American Commitment said empowering Medicare to negotiate drug prices would raid it of billions of dollars. Drug pricing experts say that that’s not the case and that such policies would instead reduce costs for the Medicare program and seniors.

By Victoria Knight and Colleen DeGuzman

July 25, 2022

Podcast

KHN’s ‘What the Health?’: Drug Price Bill Is a Go in the Senate

Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.

July 21, 2022

A family photo shows Jacob Boggs holding his daughter Emma and standing next to his daughter Riley and his wife Courtney Boggs.

Parents Become Drug Developers to Save Their Children’s Lives

Families affected by ultra-rare diseases are starting their own companies to speed the development of treatments for their kids, venturing into territory that traditional drugmakers deem too risky.

By Jared Whitlock

July 21, 2022

��ýҕ�l

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs